Low-Dose Epidural Dexmedetomidine as an Adjuvant to Bupivacaine Versus Conventional Bupivacaine for Postoperative Analgesia: A Randomized Controlled Trial

低剂量硬膜外右美托咪定作为布比卡因的辅助药物与常规布比卡因用于术后镇痛的比较:一项随机对照试验

阅读:1

Abstract

Background Epidural analgesia is widely employed in postoperative care for abdominal and lower limb surgeries, offering superior pain control, reduced opioid consumption, and improved postoperative recovery compared to systemic opioids. Objective The objective of this study is to evaluate postoperative analgesia following lower limb and abdominal procedures using low-dose epidural dexmedetomidine with 0.0625% bupivacaine against 0.125% bupivacaine. Methods Two groups of sixty American Society of Anesthesiologists (ASA) grades I and II adults undergoing elective surgery were randomly assigned: Group BB received bupivacaine 0.125%, while Group BD received epidural bupivacaine 0.0625% with dexmedetomidine (0.5 µg/kg). Over a day, assessments were made of the visual analog scale (VAS), hemodynamics, motor block (Bromage scale), Richmond Agitation-Sedation Scale (RASS), and rescue analgesia. Results Group BD required fewer rescue analgesics and had substantially lower VAS scores (p = 0.003). In the BD group without clinical hypotension, heart rate and mean arterial pressure (MAP) were somewhat lower. There was no discernible change in motor block. There were a few and controllable side effects. Conclusion The addition of dexmedetomidine to epidural bupivacaine has been shown to provide superior analgesia, enhanced hemodynamic stability, and a reduced incidence of adverse effects when compared to bupivacaine alone.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。